News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Drug Development
Antigenics Inc. (New York) Says Cancer Vaccine Study Shows Promise
October 26, 2007
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
Oct 25 (Reuters) - Antigenics Inc (AGEN.O: Quote, Profile, Research) said its potential cancer vaccine Oncophage showed promise in a mid-phase trial on 12 patients.
Twitter
LinkedIn
Facebook
Email
Print
Clinical research
Phase 2
MORE ON THIS TOPIC
Psychedelics
Lilly’s AtaiBeckley buy validates space as Big Pharma takes note of psychedelics
July 20, 2026
·
3 min read
·
Heather McKenzie
IgA nephropathy
Vertex’s IgA nephropathy drug derisked after Novartis, Vera approvals
July 20, 2026
·
2 min read
·
Tristan Manalac
Drug Development
India’s life sciences sector at turning point for innovation: Report
July 17, 2026
·
2 min read
·
Angela Gabriel
IPO
2026 IPO stock tracker: How newly public biotechs are performing
July 17, 2026
·
1 min read
·
Gabrielle Masson
